Principal Financial Group Inc. lowered its position in shares of Agilent Technologies Inc (NYSE:A) by 0.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 736,287 shares of the medical research company’s stock after selling 1,622 shares during the quarter. Principal Financial Group Inc.’s holdings in Agilent Technologies were worth $49,257,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in A. BlackRock Inc. raised its stake in Agilent Technologies by 10.8% during the first quarter. BlackRock Inc. now owns 28,445,160 shares of the medical research company’s stock valued at $1,902,983,000 after buying an additional 2,779,802 shares in the last quarter. OppenheimerFunds Inc. raised its stake in Agilent Technologies by 73.5% during the first quarter. OppenheimerFunds Inc. now owns 4,656,405 shares of the medical research company’s stock valued at $311,514,000 after buying an additional 1,973,089 shares in the last quarter. Renaissance Technologies LLC raised its stake in Agilent Technologies by 325.0% during the fourth quarter. Renaissance Technologies LLC now owns 2,370,200 shares of the medical research company’s stock valued at $158,732,000 after buying an additional 1,812,500 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in Agilent Technologies by 145.4% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,726,929 shares of the medical research company’s stock valued at $115,652,000 after buying an additional 1,023,099 shares in the last quarter. Finally, Wells Fargo & Company MN raised its stake in Agilent Technologies by 21.2% during the first quarter. Wells Fargo & Company MN now owns 2,800,486 shares of the medical research company’s stock valued at $187,353,000 after buying an additional 489,288 shares in the last quarter.
In related news, Director Heidi Fields sold 5,000 shares of the stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $68.09, for a total value of $340,450.00. Following the completion of the transaction, the director now directly owns 57,563 shares of the company’s stock, valued at approximately $3,919,464.67. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Patrick Kaltenbach sold 4,000 shares of the stock in a transaction that occurred on Thursday, March 29th. The stock was sold at an average price of $67.28, for a total value of $269,120.00. Following the completion of the transaction, the insider now directly owns 72,547 shares of the company’s stock, valued at $4,880,962.16. The disclosure for this sale can be found here.
Shares of Agilent Technologies opened at $66.32 on Wednesday, Marketbeat.com reports. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.88 and a current ratio of 3.32. The company has a market cap of $21.16 billion, a PE ratio of 28.10, a P/E/G ratio of 2.31 and a beta of 1.28. Agilent Technologies Inc has a twelve month low of $58.22 and a twelve month high of $75.00.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Monday, May 14th. The medical research company reported $0.65 earnings per share for the quarter, topping analysts’ consensus estimates of $0.64 by $0.01. Agilent Technologies had a return on equity of 18.01% and a net margin of 5.02%. The business had revenue of $1.21 billion for the quarter, compared to analysts’ expectations of $1.21 billion. During the same period in the prior year, the firm earned $0.58 EPS. The business’s quarterly revenue was up 9.4% on a year-over-year basis. research analysts expect that Agilent Technologies Inc will post 2.67 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 25th. Investors of record on Tuesday, July 3rd will be issued a $0.149 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date is Monday, July 2nd. Agilent Technologies’s dividend payout ratio (DPR) is 25.42%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.